NOTE: If you attended the live CE activity titled "Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action" that was held on March 31, 2017 during the AONE Annual Meeting in Baltimore, Maryland AND received CE credit (i.e. a nurse CE certificate), you are ineligible to also receive CE credit for this home-study activity.
Errors involving IV medications can result in significant patient harm, given the immediate bioavailability and narrow therapeutic index of many of the drugs used. This activity will address the multi-factorial risks associated with IV medications, along with the need for proven safety technologies, practice innovation, and educational strategies to enhance safety in all phases of the medication use process. Expert speakers will describe technologies available to support safe compounding and distribution practices with IV therapy, as well as the value of adopting barcoding technology and smart infusion pumps integrated with the electronic health record (EHR) to promote safe administration at the bedside.
The target audience for this activity includes nurses in health care settings. Upon completion of this activity, participants will be able to:
- Describe the system-based causes of IV medication errors.
- Identify the most common unsafe practices and at-risk behaviors associated with the preparation and administration of IV medications.
- Discuss several technologies designed to support safe practice with IV medication use.
- Recognize the role of nursing leadership in the adoption of technology and practice changes to enhance the safety of IV medication use.
Moderator: Nicole Mollenkopf, PharmD, MBA, BCPS
Johns Hopkins School of Nursing
Susan Paparella, MSN, RN
Institute for Safe Medication Practices
Michelle Mandrack, MSN, RN
Director of Consulting Services
Institute for Safe Medication Practices
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Mollenkopf, Ms. Paparella, and Ms. Mandrack have no relevant commercial or financial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 5-18-2017
Expiration Date: 5-18-2020
This CE activity is jointly provided by the Institute for Safe Medication Practices (ISMP), ProCE, Inc., and Wild Iris Medical Education, Inc. This activity provides 1.0 contact hour of nurse CE credit.
Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This CE activity is supported by an educational grant from BD.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|Activity Number||Credit Amount||Accreditation Period|
|ANCC-Nurses (625)||1 Contact Hour||May 18, 2017 - May 18, 2020|